MALVERN, Pennsylvania, January 26 /PRNewswire/ --

- Article in Gynecologic Oncology Supports Use of Fujirebio Diagnostics' HE4 Test with CA125 for Risk Stratification of Women with Suspected Ovarian Cancer

A pivotal clinical trial published in the January 2009 issue of the journal Gynecologic Oncology demonstrated the utility of combining Fujirebio Diagnostics' HE4 and the CA125 test as an aid in estimating the risk of epithelial ovarian cancer in premenopausal or postmenopausal women presenting with pelvic mass. The HE4 test, which is under review by the U.S. Food and Drug Administration (FDA), was reported to successfully stratify patients into high- and low-risk groups when combined with CA125.

FRANKFURT, Germany, January 26 /PRNewswire/ --

- Elsevier's New Web-Based Solution Combines Content From the Trusted CrossFire Databases in a Highly Intuitive and Easy to use Interface With New Features and Functionality

STOCKHOLM, January 26 /PRNewswire/ --

- International Firm Strengthens UK Market

Online advertising management firm Adtoma announced today the appointment of Ben Humphry to Managing Director of Adtoma UK Limited. In his new position, Ben will be leading operations in the UK and Ireland as well as expanding Adtoma's footprint in Europe's largest market.

PARIS, January 26 /PRNewswire/ -- Ben Verwaayen, CEO of Alcatel-Lucent (Euronext Paris and NYSE: ALU) and Paul Tufano, Chief Financial Officer will present the fourth quarter and full year 2008 results on February 4, at 1:00 pm CET (12:00 pm GMT, 7:00 am EST). The press and analyst conference will be held in the company's headquarters, 54 rue La Boétie, Paris. Please confirm your attendance at press@alcatel lucent.com.

This conference will be available live at the following address: http://www.alcatel-lucent.com/4q2008.

If you'd like to ask questions during the conference, dial-in instructions are listed below:

From the USA: 800-230-1085 From other countries: +1-612-234-9960

PRINCETON, New Jersey, January 26 /PRNewswire/ --

Mr Yohei Sasakawa, WHO Goodwill Ambassador for the Elimination of Leprosy and Japanese Government Goodwill Ambassador for the Human Rights of People Affected by Leprosy, has called for an end to the common use of the word leper.

Speaking at the launch in London of the fourth Global Appeal to End Stigma and Discrimination Against People Affected by Leprosy, held to coincide with World Leprosy Day, he said that the word carries the meaning of a pariah, or social outcast.

Mr Sasakawa said that people affected by leprosy have demanded that the term not be used.

HORSHAM, Pennsylvania, January 26 /PRNewswire/ --

- Company Selects Astea's Service Management and Mobility Solution to increase speed of service delivery and billing to cash cycle

Astea International Inc. (Nasdaq: ATEA), the leader in service lifecycle management and mobility solutions announces that ARX, the UK's leading provider of pharmacy automation, has selected Astea's Service Management and Mobile software solutions - Astea Alliance. ARX plans to use Astea Alliance to drive accurate warranty tracking, SLA compliance, engineer optimization and tighter inventory control.

ZURICH, Switzerland, January 26 /PRNewswire/ --

SVOX, the leading provider of embedded speech solutions today announced the acquisition of the Professional Speech Processing Group of Siemens AG, according to SVOX CEO Volker Jantzen. SVOX has acquired all speech technology-related IP of Siemens AG developed over 25 years, including the SpeechAdvance(TM) speech recognition product suite and more than 60 patent families. The majority of the Professional Speech Processing Group's employees will be integrated into SVOX Deutschland GmbH in Munich. SVOX Deutschland GmbH is a fully owned subsidiary of SVOX AG.

ROCKVILLE, Maryland, January 26 /PRNewswire/ --

Neuralstem, Inc. (NYSE Alternext US: CUR) today announced that it has received Official Notice of Allowance for its patent application, number 10/047,352, for Stable Neural Stem Cell Lines from the US Patent and Trade Office (USPTO). This patent covers the technology to immortalize any human neural stem cell, rendering its growth robust and long-lasting.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO)

LONDON, January 26 /PRNewswire/ --

- Most Established eBay Alternative to Spend 2008 Profits on Marketing and Site Enhancements